Norway vs Pre-demographic dividend: Immunization, measles second dose
Norway
94.0%
in 2024
Pre-demographic dividend
50.4%
in 2024
Norway rank
40th
Pre-demographic dividend rank
42nd
Immunization, measles second dose over time
- Norway
- Pre-demographic dividend
How they compare
Norway currently reports 94.0% against 50.4% in Pre-demographic dividend, a difference of 43.6%.
That makes Norway's figure about 1.9 times Pre-demographic dividend's.
Across all 25 years both countries report, Norway has been ahead every year.
Norway ranks 40th and Pre-demographic dividend ranks 42nd of 178 countries.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Norway | Pre-demographic dividend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.5% | 2.3% | 89.2% | Norway |
| 2010s | 92.6% | 14.9% | 77.7% | Norway |
| 2020s | 94.4% | 40.9% | 53.5% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Norway or Pre-demographic dividend?
- Norway, at 94.0% against 50.4% in Pre-demographic dividend as of 2024.
- What is the difference in immunization, measles second dose between Norway and Pre-demographic dividend?
- 43.6%, with Norway ahead.
- How many years of comparable data are there for Norway and Pre-demographic dividend?
- 25 years are reported by both, from 2000 to 2024.
- How do Norway and Pre-demographic dividend rank globally for immunization, measles second dose?
- Norway ranks 40th and Pre-demographic dividend ranks 42nd of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.